To watch the full video, access the recording here.
Episode 1: Vevo for Liver & NASH (Non-alcoholic steatohepatitis) Imaging
Non-alcoholic fatty liver disease (NAFLD) refers to an accumulation of excess fat in the liver and is a predominant cause of chronic liver disease. Watch to learn more about multi-modal imaging of the liver and how anatomical, functional and molecular imaging data can help to follow liver disease progression.
Topics to be Discussed
- How to assess early changes in liver structures
- Tumor detection and sizing in 2D and 3D
- How to monitor response to therapy
- Analysis of vessel architecture in the liver
- Oxygen saturation and total hemoglobin measurement of liver tissue
- Monitoring of liver tumor growth with contrast agents
- Biodistribution with whole body imaging
Episode 2: Vevo for Renal Imaging
Polycystic kidney disease, kidney cancer, renal infection, hydronephrosis, and renal malformation are just a few diseases involving the kidney. Learn more about multi-modal imaging of kidney and how non-invasive real time imaging can provide anatomical, functional and molecular data.
Topics to be Discussed
- How to monitor renal size and function non-invasively and in real-time.
- Tumor detection and sizing in 2D and 3D
- Monitoring of kidney tumor growth
- Assessing renal blood flow
- Evaluation of renal microcirculation
- Alternatives to surgery for applying treatment or inducing experimental kidney disease
- Evaluation of oxygen saturation in the Kidney
- Whole body biodistribution imaging with coregistration of ultra high resolution ultrasound and photoacoustic
Presenters
Dieter Fuchs, PhD: Market Development Manager, Fujifilm VisualSonics
Joost Holthof: Pre-Clinical Application Specialist, Fujifilm VisualSonics